Notably, SMARCD3 was negatively correlated with the immune score in SARC patients and was positively correlated with the stromal score, immune score and ESTIMATEScore in COAD, PRAD, and READ patients. The gene discussed is SMARCD3; the disease is colon adenocarcinoma.